Letter in response to: "Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N acetylcysteine for paracetamol overdosethe PP100-01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial"

Saved in:
Bibliographic Details
Published in:Trials 2019-06, Vol.20
Main Authors: Karlsson, Jan Olof, Jynge, Per, Lundström, Ingemar, Ignarro, Louis J.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue
container_start_page
container_title Trials
container_volume 20
creator Karlsson, Jan Olof
Jynge, Per
Lundström, Ingemar
Ignarro, Louis J.
description
doi_str_mv 10.1186/s13063-019-3476-3
format article
fullrecord <record><control><sourceid>swepub</sourceid><recordid>TN_cdi_swepub_primary_oai_DiVA_org_liu_158968</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>oai_DiVA_org_liu_158968</sourcerecordid><originalsourceid>FETCH-LOGICAL-s123t-9d5421d5df129f4d26eb8b03625c8596a9f0e126f4905a72277b8716518477083</originalsourceid><addsrcrecordid>eNpNj8uO1DAQRQMCiWHgA9hZswKBwY_ESWY3Gp5Si44QsI0qcbnbyIkj282Qv8fdtMSsqlR1z71VRfGCs7ecN-pd5JIpSRlvqSxrReXD4oLXZUWV4NWje_2T4mmMvxgrZSvLiwevN5gSBmJnEjAufo5Ikr8mV99g1n6yETXxC87EwYCO4J_F-QDJh_UNiWAwrSQLM-IwwGCdzYOYDnoldzbtyQhugnkHxmu72FPMAsninCJJASFl-5Mw7ZFwQff5ip2dcp435CuBMQe4cY0J7YzE-JDxcJzC5B3xvzFoH_EIdx1nLP9_Em3Pi6NLdw942W27VznYgrs-n7kEn_yYd0cOSPj_9ujnFLxzuT0RV8-KxwZcxOfneln8-Pjh--1nutl--nJ7s6GRC5loq6tScF1pw0VrSi0UDs3ApBLV2FStgtYw5EKZsmUV1ELU9dDUXFW8KeuaNfKyoP984x0uh6Ffgp0grL0H27-3P296H3a9s4eeV02rGvkX0eujiQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Letter in response to: "Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N acetylcysteine for paracetamol overdosethe PP100-01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial"</title><source>Open Access: PubMed Central</source><source>Publicly Available Content (ProQuest)</source><creator>Karlsson, Jan Olof ; Jynge, Per ; Lundström, Ingemar ; Ignarro, Louis J.</creator><creatorcontrib>Karlsson, Jan Olof ; Jynge, Per ; Lundström, Ingemar ; Ignarro, Louis J.</creatorcontrib><identifier>ISSN: 1745-6215</identifier><identifier>EISSN: 1745-6215</identifier><identifier>DOI: 10.1186/s13063-019-3476-3</identifier><language>eng</language><ispartof>Trials, 2019-06, Vol.20</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27923,27924</link.rule.ids><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-158968$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Karlsson, Jan Olof</creatorcontrib><creatorcontrib>Jynge, Per</creatorcontrib><creatorcontrib>Lundström, Ingemar</creatorcontrib><creatorcontrib>Ignarro, Louis J.</creatorcontrib><title>Letter in response to: "Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N acetylcysteine for paracetamol overdosethe PP100-01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial"</title><title>Trials</title><issn>1745-6215</issn><issn>1745-6215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNpNj8uO1DAQRQMCiWHgA9hZswKBwY_ESWY3Gp5Si44QsI0qcbnbyIkj282Qv8fdtMSsqlR1z71VRfGCs7ecN-pd5JIpSRlvqSxrReXD4oLXZUWV4NWje_2T4mmMvxgrZSvLiwevN5gSBmJnEjAufo5Ikr8mV99g1n6yETXxC87EwYCO4J_F-QDJh_UNiWAwrSQLM-IwwGCdzYOYDnoldzbtyQhugnkHxmu72FPMAsninCJJASFl-5Mw7ZFwQff5ip2dcp435CuBMQe4cY0J7YzE-JDxcJzC5B3xvzFoH_EIdx1nLP9_Em3Pi6NLdw942W27VznYgrs-n7kEn_yYd0cOSPj_9ujnFLxzuT0RV8-KxwZcxOfneln8-Pjh--1nutl--nJ7s6GRC5loq6tScF1pw0VrSi0UDs3ApBLV2FStgtYw5EKZsmUV1ELU9dDUXFW8KeuaNfKyoP984x0uh6Ffgp0grL0H27-3P296H3a9s4eeV02rGvkX0eujiQ</recordid><startdate>20190624</startdate><enddate>20190624</enddate><creator>Karlsson, Jan Olof</creator><creator>Jynge, Per</creator><creator>Lundström, Ingemar</creator><creator>Ignarro, Louis J.</creator><scope>ABXSW</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8T</scope><scope>DG8</scope><scope>ZZAVC</scope></search><sort><creationdate>20190624</creationdate><title>Letter in response to: "Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N acetylcysteine for paracetamol overdosethe PP100-01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial"</title><author>Karlsson, Jan Olof ; Jynge, Per ; Lundström, Ingemar ; Ignarro, Louis J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-s123t-9d5421d5df129f4d26eb8b03625c8596a9f0e126f4905a72277b8716518477083</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Karlsson, Jan Olof</creatorcontrib><creatorcontrib>Jynge, Per</creatorcontrib><creatorcontrib>Lundström, Ingemar</creatorcontrib><creatorcontrib>Ignarro, Louis J.</creatorcontrib><collection>SWEPUB Linköpings universitet full text</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SWEPUB Linköpings universitet</collection><collection>SwePub Articles full text</collection><jtitle>Trials</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Karlsson, Jan Olof</au><au>Jynge, Per</au><au>Lundström, Ingemar</au><au>Ignarro, Louis J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Letter in response to: "Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N acetylcysteine for paracetamol overdosethe PP100-01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial"</atitle><jtitle>Trials</jtitle><date>2019-06-24</date><risdate>2019</risdate><volume>20</volume><issn>1745-6215</issn><eissn>1745-6215</eissn><doi>10.1186/s13063-019-3476-3</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1745-6215
ispartof Trials, 2019-06, Vol.20
issn 1745-6215
1745-6215
language eng
recordid cdi_swepub_primary_oai_DiVA_org_liu_158968
source Open Access: PubMed Central; Publicly Available Content (ProQuest)
title Letter in response to: "Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N acetylcysteine for paracetamol overdosethe PP100-01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial"
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T20%3A03%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-swepub&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Letter%20in%20response%20to:%20%22Randomised%20open%20label%20exploratory,%20safety%20and%20tolerability%20study%20with%20calmangafodipir%20in%20patients%20treated%20with%20the%2012-h%20regimen%20of%20N%20acetylcysteine%20for%20paracetamol%20overdosethe%20PP100-01%20for%20Overdose%20of%20Paracetamol%20(POP)%20trial:%20study%20protocol%20for%20a%20randomised%20controlled%20trial%22&rft.jtitle=Trials&rft.au=Karlsson,%20Jan%20Olof&rft.date=2019-06-24&rft.volume=20&rft.issn=1745-6215&rft.eissn=1745-6215&rft_id=info:doi/10.1186/s13063-019-3476-3&rft_dat=%3Cswepub%3Eoai_DiVA_org_liu_158968%3C/swepub%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-s123t-9d5421d5df129f4d26eb8b03625c8596a9f0e126f4905a72277b8716518477083%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true